Onconova Therapeutics (ONTX) Short Interest Ratio & Short Volume → READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad) Free ONTX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesShort InterestSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesShort InterestSocial Media Onconova Therapeutics Short Interest DataCurrent Short Volume26,200 sharesPrevious Short Volume20,700 sharesChange Vs. Previous Month+26.57%Dollar Volume Sold Short$26,462.00Short Interest Ratio / Days to Cover0.6Last Record DateMarch 31, 2024Outstanding Shares21,000,000 sharesPercentage of Shares Shorted0.12%Today's Trading Volume1,281,800 sharesAverage Trading Volume96,681 sharesToday's Volume Vs. Average1,326% Short Selling Onconova Therapeutics ? Sign up to receive the latest short interest report for Onconova Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatONTX Short Interest Over TimeONTX Days to Cover Over TimeONTX Percentage of Float Shorted Over Time Ad Stansberry ResearchHUGE BUY ALERT: Move Fast, Musk...I recently traveled to Phoenix, Arizona...And based on what I saw out there, I'm prepared to put my reputation on the line. Since 2018, my investment recommendations have averaged 115% per year. But one investment I've just discovered could blow them all away.You won't believe what I saw in Phoenix. Onconova Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202426,200 shares $26,462.00 +26.6%N/A0.6 $1.01 3/15/202420,700 shares $17,230.68 -58.9%N/A0.3 $0.83 2/29/202450,300 shares $39,686.70 +61.7%N/A0.2 $0.79 2/15/202431,100 shares $21,645.60 -42.9%N/A0.1 $0.70 1/31/202454,500 shares $37,114.50 -44.8%N/A0.2 $0.68 1/15/202498,700 shares $70,175.70 -30.5%N/A0.4 $0.71 Get the Latest News and Ratings for ONTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Onconova Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023142,100 shares $105,949.76 -51.5%N/A0.5 $0.75 12/15/2023293,000 shares $224,701.70 +694.0%N/A1.1 $0.77 11/30/202336,900 shares $25,424.10 -56.8%N/A0.3 $0.69 11/15/202385,500 shares $53,950.50 +21.1%N/A1.2 $0.63 10/31/202370,600 shares $44,520.36 +9.0%N/A1 $0.63 10/15/202364,800 shares $43,422.48 +27.8%N/A0.8 $0.67 9/30/202350,700 shares $36,067.98 -36.2%N/A1 $0.71 9/15/202379,400 shares $64,306.06 +23.9%N/A1.4 $0.81 8/31/202364,100 shares $50,382.60 -28.1%N/A1 $0.79 8/15/202389,100 shares $77,802.12 -15.5%N/A1.3 $0.87 7/31/2023105,400 shares $109,616.00 -38.0%N/A1.2 $1.04 7/15/2023170,000 shares $188,700.00 -22.3%N/A0.3 $1.11 6/30/2023218,700 shares $258,066.00 -17.9%N/A0.4 $1.18 6/15/2023266,500 shares $322,465.00 -0.3%N/A0.5 $1.21 5/31/2023267,200 shares $312,624.00 -8.3%N/A0.5 $1.17 5/15/2023291,400 shares $343,852.00 -24.8%N/A0.5 $1.18 4/30/2023387,400 shares $445,510.00 +982.1%N/A0.7 $1.15 4/15/202335,800 shares $24,165.00 +49.2%N/A0.1 $0.68 3/31/202324,000 shares $17,536.80 -38.5%N/A0.1 $0.73 3/15/202339,000 shares $28,587.00 +20.4%N/A0.2 $0.73 2/28/202332,400 shares $26,276.40 +68.8%N/A0.2 $0.81 2/15/202319,200 shares $17,362.56 +64.1%N/A0.1 $0.90 1/31/202311,700 shares $14,625.00 +54.0%N/A0.1 $1.25 1/15/20237,600 shares $6,687.25 -12.6%N/A0.1 $0.88 12/30/20228,700 shares $5,617.59 +19.2%N/A0.1 $0.65 12/15/20227,300 shares $5,158.55 -42.1%N/A0.1 $0.71 11/30/202212,600 shares $10,521.00 -23.2%N/A0.2 $0.84 11/15/202216,400 shares $13,776.00 -58.8%N/A0.2 $0.84 10/31/202239,800 shares $28,656.00 +186.3%N/A0.6 $0.72 10/15/202213,900 shares $9,727.22 -9.7%N/A0.1 $0.70 9/30/202215,400 shares $13,567.40 -16.8%N/A0.2 $0.88 9/15/202218,500 shares $21,645.00 -33.5%N/A0.2 $1.17 8/31/202227,800 shares $33,221.00 +86.6%N/A0.3 $1.20 8/15/202214,900 shares $18,923.00 -12.9%N/A0.1 $1.27America could fall from this event (Ad)America’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that, if successful, could be more financially and culturally devastating than the dot-com blowup of 2000, the 2008 financial crisis, or the COVID crash.Click here to see how you can protect yourself today. ONTX Short Interest - Frequently Asked Questions What is Onconova Therapeutics' current short interest? Short interest is the volume of Onconova Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 26,200 shares of ONTX short. Learn More on Onconova Therapeutics' current short interest. What is a good short interest ratio for Onconova Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ONTX shares currently have a short interest ratio of 1.0. Learn More on Onconova Therapeutics's short interest ratio. Is Onconova Therapeutics' short interest increasing or decreasing? Onconova Therapeutics saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 26,200 shares, an increase of 26.6% from the previous total of 20,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Onconova Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Onconova Therapeutics: Sol-Gel Technologies Ltd. (0.04%), MEI Pharma, Inc. (0.37%), Alaunos Therapeutics, Inc. (9.57%), Benitec Biopharma Inc. (6.27%), Synlogic, Inc. (0.36%), RenovoRx, Inc. (0.19%), GlycoMimetics, Inc. (9.45%), KALA BIO, Inc. (0.36%), BioVie Inc. (3.18%), Cumberland Pharmaceuticals Inc. (0.23%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Onconova Therapeutics stock? Short selling ONTX is an investing strategy that aims to generate trading profit from Onconova Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Onconova Therapeutics? A short squeeze for Onconova Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ONTX, which in turn drives the price of the stock up even further. How often is Onconova Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ONTX, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Sol-Gel Technologies Short Interest MEI Pharma Short Interest Alaunos Therapeutics Short Interest Benitec Biopharma Short Interest Synlogic Short Interest RenovoRx Short Interest GlycoMimetics Short Interest KALA BIO Short Interest BioVie Short Interest Cumberland Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ONTX) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperElon to Transform U.S. Economy? Porter & Company